Domenico Albano (D Albano)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 72

Top Topics

Prognostic Factors

Positron Emission Tomography

Top Venues

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, Rosa Sciuto, Silvia Di Traglia, Matteo Bauckneht, Francesco Lanfranchi, Silvia Morbelli, Anna Giulia Nappi, Cristina Ferrari, Giuseppe Rubini, Stefano Panareo, Luca Urso, Mirco Bartolomei, Davide D'Arienzo, Tullio Valente, Virginia Rossetti, Paola Caroli, Federica Matteucci, Demetrio Aricò, Michelangelo Bombaci, Domenica Caponnetto, Francesco Bertagna, Domenico Albano, Francesco Dondi, Sara Gusella, Alessandro Spimpolo, Cinzia Carriere, Michele Balma, Ambra Buschiazzo, Rosj Gallicchio, Giovanni Storto, Livia Ruffini, Veronica Cervati, Roberta Eufrasia Ledda, Anna Rita Cervino, Lea Cuppari, Marta Burei, Giuseppe Trifirò, Elisabetta Brugola, Carolina Arianna Zanini, Alessandra Alessi, Valentina Fuoco, Ettore Seregni, Desiree' Deandreis, Virginia Liberini, Antonino Maria Moreci, Salvatore Ialuna, Sabina Pulizzi, Maria Luisa De Rimini
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors. Cancers 15 (3) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 15 (2) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 15 (2) (2023)
Domenico Albano, Pietro Bellini, Francesco Dondi, Anna Calabrò, Claudio Casella, Stefano Taboni, Davide Lombardi, Giorgio Treglia, Francesco Bertagna
Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine. Cancers 15 (4) (2023)
Domenico Albano, Giorgio Treglia, Francesco Dondi, Anna Calabrò, Alessio Rizzo, Salvatore Annunziata, Luca Guerra, Silvia Morbelli, Alessandra Tucci, Francesco Bertagna
18 F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? Cancers 15 (9) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Roberto C Delgado Bolton, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Alessio Rizzo, Manuela Racca, Federico Garrou, Elisabetta Fenocchio, Luca Pellegrino, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (12) (2023)
Francesco Dondi, Alessandro Antonelli, Nazareno Suardi, Andrea Emanuele Guerini, Domenico Albano, Silvia Lucchini, Luca Camoni, Giorgio Treglia, Francesco Bertagna
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review. Cancers 15 (17) (2023)
Domenico Albano, Pietro Bellini, Francesco Dondi, Anna Calabrò, Claudio Casella, Stefano Taboni, Davide Lombardi, Giorgio Treglia, Francesco Bertagna
Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine. Cancers 15 (4) (2023)
Alessio Rizzo, Manuela Racca, Federico Garrou, Elisabetta Fenocchio, Luca Pellegrino, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (12) (2023)
Domenico Albano, Giorgio Treglia, Francesco Dondi, Anna Calabrò, Alessio Rizzo, Salvatore Annunziata, Luca Guerra, Silvia Morbelli, Alessandra Tucci, Francesco Bertagna
18 F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? Cancers 15 (9) (2023)
Alessio Rizzo, Manuela Racca, Federico Garrou, Elisabetta Fenocchio, Luca Pellegrino, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (12) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Roberto C Delgado Bolton, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, Rosa Sciuto, Silvia Di Traglia, Matteo Bauckneht, Francesco Lanfranchi, Silvia Morbelli, Anna Giulia Nappi, Cristina Ferrari, Giuseppe Rubini, Stefano Panareo, Luca Urso, Mirco Bartolomei, Davide D'Arienzo, Tullio Valente, Virginia Rossetti, Paola Caroli, Federica Matteucci, Demetrio Aricò, Michelangelo Bombaci, Domenica Caponnetto, Francesco Bertagna, Domenico Albano, Francesco Dondi, Sara Gusella, Alessandro Spimpolo, Cinzia Carriere, Michele Balma, Ambra Buschiazzo, Rosj Gallicchio, Giovanni Storto, Livia Ruffini, Veronica Cervati, Roberta Eufrasia Ledda, Anna Rita Cervino, Lea Cuppari, Marta Burei, Giuseppe Trifirò, Elisabetta Brugola, Carolina Arianna Zanini, Alessandra Alessi, Valentina Fuoco, Ettore Seregni, Desiree' Deandreis, Virginia Liberini, Antonino Maria Moreci, Salvatore Ialuna, Sabina Pulizzi, Maria Luisa De Rimini
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors. Cancers 15 (3) (2023)
Alessio Rizzo, Manuela Racca, Sara Dall'Armellina, Pasquale Rescigno, Giuseppe Luigi Banna, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers 15 (2) (2023)
Giorgio Treglia, Chiara Martinello, Francesco Dondi, Domenico Albano, Francesco Bertagna, Alessio Rizzo, Roberto C Delgado Bolton, Gregorio Tersalvi, Barbara Muoio, Martin Riegger, Diego Cecchin
Prevalence of Incidental Findings Suspicious for Transthyretin Cardiac Amyloidosis among Patients Undergoing Bone Scintigraphy: A Systematic Review and a Meta-Analysis. Journal of clinical medicine 12 (17) (2023)
Domenico Albano, Francesco Dondi, Francesco Bertagna, Giorgio Treglia
The Role of [ 68 Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review. Cancers 14 (15) (2022)
Francesco Dondi, Roberto Gatta, Domenico Albano, Pietro Bellini, Luca Camoni, Giorgio Treglia, Francesco Bertagna
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [ 18 F]FDG PET/CT: A Comparison between Two PET/CT Scanners. Journal of clinical medicine 12 (1) (2022)
Francesco Dondi, Domenico Albano, Francesco Bertagna, Raffaele Giubbini
[18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation? Nuclear medicine review. Central & Eastern Europe 25 (2) (2022)
Domenico Albano, Giorgio Treglia, Francesco Dondi, Francesco Bertagna
Prevalence of Brain Incidental Lesions Detected by 68 Ga-DOTA Peptides PET/CT. Medicina (Kaunas, Lithuania) 58 (7) (2022)
Domenico Albano, Nadia Pasinetti, Francesco Dondi, Raffaele Giubbini, Alessandra Tucci, Francesco Bertagna
Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[ 18 F]-FDG PET/CT in Elderly Mantle Cell Lymphoma. Journal of clinical medicine 11 (5) (2022)
Francesco Dondi, Domenico Albano, Francesco Bertagna, Giorgio Treglia
Bone Scintigraphy versus PSMA-Targeted PET/CT or PET/MRI in Prostate Cancer: Lessons Learned from Recent Systematic Reviews and Meta-Analyses. Cancers 14 (18) (2022)
Domenico Albano, Francesco Dondi, Matteo Bauckneht, Manuela Albertelli, Rexhep Durmo, Angelina Filice, Annibale Versari, Silvia Morbelli, Alfredo Berruti, Francesco Bertagna
The diagnostic and prognostic role of combined [ 18 F]FDG and [ 68 Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience. European radiology (2022)
Elizabeth Katherine Anna Triumbari, David Morland, Riccardo Laudicella, Matteo Bauckneht, Domenico Albano, Salvatore Annunziata
Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review. Cancers 14 (14) (2022)
Francesco Dondi, Domenico Albano, Pietro Bellini, Luca Camoni, Giorgio Treglia, Francesco Bertagna
Relationship between Baseline [ 18 F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma. Tomography (Ann Arbor, Mich.) 8 (6) (2022)
Alessio Rizzo, Manuela Racca, Domenico Albano, Francesco Dondi, Francesco Bertagna, Salvatore Annunziata, Giorgio Treglia
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Francesco Dondi, Roberto Gatta, Domenico Albano, Pietro Bellini, Luca Camoni, Giorgio Treglia, Francesco Bertagna
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [ 18 F]FDG PET/CT: A Comparison between Two PET/CT Scanners. Journal of clinical medicine 12 (1) (2022)
Barbara Muoio, Domenico Albano, Francesco Dondi, Francesco Bertagna, Valentina Garibotto, Jolanta Kunikowska, Arnoldo Piccardo, Salvatore Annunziata, Vittoria Espeli, Denis Migliorini, Giorgio Treglia
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis. Diagnostics (Basel, Switzerland) 12 (7) (2022)
Francesco Dondi, Domenico Albano, Giorgio Treglia, Francesco Bertagna
Could [ 18 F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis? Diagnostics (Basel, Switzerland) 12 (9) (2022)
Francesco Dondi, Roberto Gatta, Domenico Albano, Pietro Bellini, Luca Camoni, Giorgio Treglia, Francesco Bertagna
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [ 18 F]FDG PET/CT: A Comparison between Two PET/CT Scanners. Journal of clinical medicine 12 (1) (2022)
Francesco Dondi, Nadia Pasinetti, Roberto Gatta, Domenico Albano, Raffaele Giubbini, Francesco Bertagna
Comparison between Two Different Scanners for the Evaluation of the Role of 18 F-FDG PET/CT Semiquantitative Parameters and Radiomics Features in the Prediction of Final Diagnosis of Thyroid Incidentalomas. Journal of clinical medicine 11 (3) (2022)
Domenico Albano, Francesco Dondi, Giorgio Treglia, Alessandra Tucci, Marco Ravanelli, Davide Farina, Francesco Bertagna
Longitudinal Body Composition Changes Detected by [ 18 F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma. Cancers 14 (20) (2022)
Francesco Dondi, Domenico Albano, Giorgio Treglia, Francesco Bertagna
Emerging Role of FAPI PET Imaging for the Assessment of Benign Bone and Joint Diseases. Journal of clinical medicine 11 (15) (2022)
Francesco Dondi, Domenico Albano, Giorgio Treglia, Francesco Bertagna
Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold! Journal of clinical medicine 11 (18) (2022)
Domenico Albano, Giorgio Treglia, Francesco Dondi, Raffaele Giubbini, Alessandro Galani, Carlo Cappelli, Francesco Bertagna, Claudio Casella
Comparison between total thyroidectomy and hemithyroidectomy in TIR3B thyroid nodules management. Endocrine 78 (2) (2022)
Domenico Albano, Francesco Dondi, Valentina Zilioli, Maria Beatrice Panarotto, Alessandro Galani, Carlo Cappelli, Francesco Bertagna, Raffaele Giubbini, Claudio Casella
The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer. Annals of nuclear medicine 35 (10) (2021)
Angelina Cistaro, Natale Quartuccio, Maria Carmen Garganese, Maria Felicia Villani, Claudio Altini, Milena Pizzoferro, Arnoldo Piccardo, Manlio Cabria, Michela Massollo, Mohamad Maghnie, Alfredo Campennì, Massimiliano Siracusa, Sergio Baldari, Stefano Panareo, Luca Urso, Mirco Bartolomei, Diego De Palma, Armando Grossi, Angelica Mazzoletti, Francesco Dondi, Francesco Bertagna, Raffaele Giubbini, Domenico Albano
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study. European journal of nuclear medicine and molecular imaging (2021)
Domenico Albano, Mattia Bonacina, Giordano Savelli, Paola Ferro, Elena Busnardo, Luigi Gianolli, Luca Camoni, Raffaele Giubbini, Francesco Bertagna
Clinical and prognostic 18F-FDG PET/CT role in recurrent vulvar cancer: a multicentric experience. Japanese journal of radiology (2021)
Domenico Albano, Raffaele Giubbini, Francesco Bertagna
Thyroid metastasis from lung carcinoid detected by 68Ga-DOTATOC PET/CT. Endocrine 74 (1) (2021)
Domenico Albano, Francesco Dondi, Angelica Mazzoletti, Pietro Bellini, Raffaele Giubbini, Francesco Bertagna
Prognostic Impact of Pretreatment 2-[18F]-FDG PET/CT Parameters in Primary Gastric DLBCL. Medicina (Kaunas, Lithuania) 57 (5) (2021)
Giorgio Treglia, Francesco Bertagna, Domenico Albano
The "Undetermined Significance" of 18F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS). Medicina (Kaunas, Lithuania) 57 (8) (2021)
Luca Camoni, Domenico Albano
Contrast-enhanced 18F-FDG PET/CT to differentiate primary cardiac lymphoma from primary cardiac angiosarcoma. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology (2021)
Domenico Albano
Metabolic tumor volume as prognostic factor in pediatric Hodgkin lymphoma: Dream or reality? Pediatric blood & cancer 68 (9) (2021)
Domenico Albano, Bonacina Mattia, Raffaele Giubbini, Francesco Bertagna
Role of 18F-FDG PET/CT in restaging and follow-up of patients with GIST. Abdominal radiology (New York) 45 (3) (2021)
Marco Ravanelli, Alberto Grammatica, Guido Squassina, Francesco Bertagna, Domenico Albano, Davide Lancini, Paolo Bosio, Angelo Zigliani, Giorgio Maria Agazzi, Roberto Maroldi, Piero Nicolai, Raffaele Giubbini, Cesare Piazza, Davide Farina
Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients. Nuclear medicine review. Central & Eastern Europe 24 (2) (2021)
Domenico Albano, Mark Tulchinsky, Francesco Dondi, Angelica Mazzoletti, Francesco Bertagna, Raffaele Giubbini
The role of Tg kinetics in predicting 2-[18F]-FDG PET/CT results and overall survival in patients affected by differentiated thyroid carcinoma with detectable Tg and negative 131I-scan. Endocrine 74 (2) (2021)
Angelina Cistaro, Domenico Albano, Pierpaolo Alongi, Riccardo Laudicella, Daniele Antonio Pizzuto, Giuseppe Formica, Cinzia Romagnolo, Federica Stracuzzi, Viviana Frantellizzi, Arnoldo Piccardo, Natale Quartuccio
The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors. Current oncology (Toronto, Ont.) 28 (4) (2021)
Domenico Albano, Roberto Gatta, Matteo Marini, Carlo Rodella, Luca Camoni, Francesco Dondi, Raffaele Giubbini, Francesco Bertagna
Role of 18F-FDG PET/CT Radiomics Features in the Differential Diagnosis of Solitary Pulmonary Nodules: Diagnostic Accuracy and Comparison between Two Different PET/CT Scanners. Journal of clinical medicine 10 (21) (2021)
Maria Gazzilli, Domenico Albano, Laura Ardighieri, Francesco Bertagna, Raffaele Giubbini
Primary nasal-ethmoid choriocarcinoma detected by 18F-FDG PET/CT: a rare tumor with complete remission. Nuclear medicine review. Central & Eastern Europe 23 (2) (2021)
Domenico Albano, Francesco Dondi, Angelica Mazzoletti, Pietro Bellini, Carlo Rodella, Francesco Bertagna
Prognostic Role of 2-[ 18 F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative 131 I WBS and Positive 2-[ 18 F]-FDG PET/CT. Diagnostics (Basel, Switzerland) 11 (12) (2021)
Domenico Albano, Francesco Bertagna, Pierpaolo Alongi, Sergio Baldari, Alfonso Baldoncini, Mirco Bartolomei, Franco Boccaletto, Michele Boero, Eugenio Borsatti, Andrea Bruno, Luca Burroni, Francesca Capoccetti, Massimo Castellani, Anna Rita Cervino, Franca Chierichetti, Andrea Ciarmiello, Angelo Corso, Alberto Cuocolo, Maria Luisa De Rimini, Desiree' Deandreis, Massimo Eugenio Dottorini, Filomena Esposito, Mohsen Farsad, Massimo Gasparini, Chiara Maria Grana, Michele Gregianin, Luca Guerra, Fabio Loreti, Andrea Lupi, Gianluigi Martino, Elisa Milan, Sergio Modoni, Silvia Morbelli, Alfredo Muni, Emanuele Nicolai, Barbara Palumbo, Sergio Papa, Alberto Papaleo, Riccardo Pellerito, Carlo Poti, Pasquale Romano, Claudio Rossetti, Pierluigi Rossini, Giuseppe Rubini, Livia Ruffini, Gianmauro Sacchetti, Giordano Savelli, Saverio Schiavariello, Roberto Sciagrà, Rosa Sciuto, Ettore Seregni, Stelvio Sestini, Michele Sicolo, Angela Spanu, Giovanni Storto, Massimo Tosti Balducci, Giuseppe Trifirò, Annibale Versari, Alberto Vignati, Duccio Volterrani, Maria Lucia Calcagni, Maria Cristina Marzola, Antonio Garufo, Laura Evangelista, Roberto Maroldi, Orazio Schillaci, Raffaele Giubbini, null null
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study. European journal of nuclear medicine and molecular imaging 48 (9) (2021)
Domenico Albano, Angelica Mazzoletti, Vittorio Ruggero Zilioli, Cristina Muzi, Lara Crucitti, Alessandra Tucci, Chiara Pagani, Alessandro Re, Claudio Rossetti, Raffaele Giubbini, Francesco Bertagna
Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experience. Leukemia & lymphoma 61 (13) (2020)
Salvatore Annunziata, Roberto C Delgado Bolton, Christel-Hermann Kamani, John O Prior, Domenico Albano, Francesco Bertagna, Giorgio Treglia
Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Domenico Albano, Raffaele Giubbini, Francesco Bertagna
18F-FDG PET/CT in splenic marginal zone lymphoma. Abdominal radiology (New York) 43 (10) (2020)
Domenico Albano, Mark Tulchinsky, Francesco Dondi, Angelica Mazzoletti, Davide Lombardi, Francesco Bertagna, Raffaele Giubbini
Thyroglobulin doubling time offers a better threshold than thyroglobulin level for selecting optimal candidates to undergo localizing [18F]FDG PET/CT in non-iodine avid differentiated thyroid carcinoma. European journal of nuclear medicine and molecular imaging 48 (2) (2020)
Carmelo Messina, A C Buzzoni, S Gitto, J Almolla, Domenico Albano, Luca Maria Sconfienza
Disruption of bone densitometry practice in a Northern Italy Orthopedic Hospital during the COVID-19 pandemic. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (1) (2020)
Domenico Albano, Mark Tulchinsky, Francesco Bertagna, Raffaele Giubbini
Response to the letter to the editor "18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I". European journal of nuclear medicine and molecular imaging 47 (13) (2020)
Domenico Albano, Giovanni Bosio, Davide Tomasini, Marco Bonù, Raffaele Giubbini, Francesco Bertagna
Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist. Asia-Pacific journal of clinical oncology 16 (5) (2020)
Matteo Bauckneht, Domenico Albano, Salvatore Annunziata, Giulia Santo, Priscilla Guglielmo, Viviana Frantellizzi, Alessia Branca, Cristina Ferrari, Antonio Vento, Alessia Mirabile, Anna Giulia Nappi, Laura Evangelista, Pierpaolo Alongi, Riccardo Laudicella
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis. Diagnostics (Basel, Switzerland) 10 (8) (2020)
Domenico Albano, Giorgio Treglia, Luca Giovanella, Raffaele Giubbini, Francesco Bertagna
Detection of thyroiditis on PET/CT imaging: a systematic review. Hormones (Athens, Greece) 19 (3) (2020)
Domenico Albano, Riccardo Laudicella, Paola Ferro, Michela Allocca, Elisabetta Abenavoli, Ambra Buschiazzo, Alessia Castellino, Agostino Chiaravalloti, Annarosa Cuccaro, Lea Cuppari, Rexhep Durmo, Laura Evangelista, Viviana Frantellizzi, Sofya Kovalchuk, Flavia Linguanti, Giulia Santo, Matteo Bauckneht, Salvatore Annunziata, null null
The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study. Cancers 11 (12) (2019)
Riccardo Laudicella, Domenico Albano, Salvatore Annunziata, Diletta Calabrò, Giovanni Argiroffi, Elisabetta Abenavoli, Flavia Linguanti, Domenico Albano, Antonio Vento, Antonio Bruno, Pierpaolo Alongi, Matteo Bauckneht
Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications. Cancers 11 (10) (2019)
Domenico Albano, Alessandro Re, Alessandra Tucci, Raffaele Giubbini, Francesco Bertagna
Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma. Annals of nuclear medicine 33 (4) (2019)
Domenico Albano, Giovanni Bosio, Nicola Bianchetti, Chiara Pagani, Alessandro Re, Alessandra Tucci, Raffaele Giubbini, Francesco Bertagna
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma. Annals of nuclear medicine 33 (7) (2019)
Domenico Albano, Davide Tomasini, Marco Bonù, Raffaele Giubbini, Francesco Bertagna
18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas. Annals of nuclear medicine 34 (2) (2019)
Domenico Albano, Raffaele Giubbini, Francesco Bertagna
13N-NH3 PET/CT in oncological disease. Japanese journal of radiology 37 (12) (2019)
Domenico Albano, Mattia Bonacina, Rexhep Durmo, Francesco Bertagna, Raffaele Giubbini
Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer. Endocrine 68 (1) (2019)
Domenico Albano, Giovanni Bosio, Chiara Pagani, Alessandro Re, Alessandra Tucci, Raffaele Giubbini, Francesco Bertagna
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. European journal of nuclear medicine and molecular imaging 46 (1) (2018)
Domenico Albano, Rexhep Durmo, Francesco Bertagna, Raffaele Giubbini
18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer. Endocrine 63 (3) (2018)
Domenico Albano, Giovanni Bosio, Luca Camoni, Mirko Farina, Alessandro Re, Alessandra Tucci, Raffaele Giubbini, Francesco Bertagna
Prognostic role of baseline 18 F-FDG PET/CT parameters in MALT lymphoma. Hematological oncology 37 (1) (2018)
Domenico Albano, Mattia Bertoli, Marco Battistotti, Carlo Rodella, Massimo Statuto, Raffaele Giubbini, Francesco Bertagna
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma. Annals of nuclear medicine 32 (8) (2018)
Domenico Albano, Giovanni Bosio, Mattia Bertoli, Raffaele Giubbini, Francesco Bertagna
18F-FDG PET/CT in primary brain lymphoma. Journal of neuro-oncology 136 (3) (2017)